221 related articles for article (PubMed ID: 27138757)
1. Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery.
Sharma R; Khan IA
Curr Drug Targets; 2017; 18(14):1587-1597. PubMed ID: 27138757
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution.
Kostrewa D; D'Arcy A; Takacs B; Kamber M
J Mol Biol; 2001 Jan; 305(2):279-89. PubMed ID: 11124906
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.
Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J
Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115
[TBL] [Abstract][Full Text] [Related]
4. Characterization of substrate binding and catalysis in the potential antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
Mochalkin I; Lightle S; Zhu Y; Ohren JF; Spessard C; Chirgadze NY; Banotai C; Melnick M; McDowell L
Protein Sci; 2007 Dec; 16(12):2657-66. PubMed ID: 18029420
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the bifunctional N-acetylglucosamine 1-phosphate uridyltransferase from Escherichia coli: a paradigm for the related pyrophosphorylase superfamily.
Brown K; Pompeo F; Dixon S; Mengin-Lecreulx D; Cambillau C; Bourne Y
EMBO J; 1999 Aug; 18(15):4096-107. PubMed ID: 10428949
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
8. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
[TBL] [Abstract][Full Text] [Related]
9. Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site.
Mochalkin I; Lightle S; Narasimhan L; Bornemeier D; Melnick M; Vanderroest S; McDowell L
Protein Sci; 2008 Mar; 17(3):577-82. PubMed ID: 18218712
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
Sharma R; Lambu MR; Jamwal U; Rani C; Chib R; Wazir P; Mukherjee D; Chaubey A; Khan IA
J Biomol Screen; 2016 Apr; 21(4):342-53. PubMed ID: 26762501
[TBL] [Abstract][Full Text] [Related]
11. Novel lead compound optimization and synthesized based on the target structure of Xanthomonas oryzae pv. oryzae GlmU.
Qi X; Deng W; Gao M; Mao B; Xu S; Chen C; Zhang Q
Pestic Biochem Physiol; 2015 Jul; 122():22-8. PubMed ID: 26071803
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel active site architecture.
Sulzenbacher G; Gal L; Peneff C; Fassy F; Bourne Y
J Biol Chem; 2001 Apr; 276(15):11844-51. PubMed ID: 11118459
[TBL] [Abstract][Full Text] [Related]
13. GlmU Inhibitors as Promising Antibacterial Agents: A Review.
Palathoti N; Azam MA
Mini Rev Med Chem; 2023; 23(3):343-360. PubMed ID: 35980047
[TBL] [Abstract][Full Text] [Related]
14. Renew or die: The molecular mechanisms of peptidoglycan recycling and antibiotic resistance in Gram-negative pathogens.
DomÃnguez-Gil T; Molina R; Alcorlo M; Hermoso JA
Drug Resist Updat; 2016 Sep; 28():91-104. PubMed ID: 27620957
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides.
Stokes SS; Albert R; Buurman ET; Andrews B; Shapiro AB; Green OM; McKenzie AR; Otterbein LR
Bioorg Med Chem Lett; 2012 Dec; 22(23):7019-23. PubMed ID: 23099094
[TBL] [Abstract][Full Text] [Related]
16. Dissection of the bifunctional Escherichia coli N-acetylglucosamine-1-phosphate uridyltransferase enzyme into autonomously functional domains and evidence that trimerization is absolutely required for glucosamine-1-phosphate acetyltransferase activity and cell growth.
Pompeo F; Bourne Y; van Heijenoort J; Fassy F; Mengin-Lecreulx D
J Biol Chem; 2001 Feb; 276(6):3833-9. PubMed ID: 11084021
[TBL] [Abstract][Full Text] [Related]
17. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
[TBL] [Abstract][Full Text] [Related]
19. Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli.
Gehring AM; Lees WJ; Mindiola DJ; Walsh CT; Brown ED
Biochemistry; 1996 Jan; 35(2):579-85. PubMed ID: 8555230
[TBL] [Abstract][Full Text] [Related]
20. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis.
Mengin-Lecreulx D; van Heijenoort J
J Bacteriol; 1994 Sep; 176(18):5788-95. PubMed ID: 8083170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
